Health Net Announces Appearance at Goldman Sachs Healthcare CEOs Unscripted Conference
December 31 2014 - 8:30AM
Business Wire
Health Net, Inc. (NYSE:HNT) today announced that members of its
management team are scheduled to present at the Goldman Sachs
Healthcare CEOs Unscripted Conference on January 6, 2015, at
approximately 1:00 p.m. Eastern time.
A live webcast and replay of the presentation will be available
at www.healthnet.com under “Investor Relations.” The webcast is
open to all interested parties. The webcast should be accessed at
least 15 minutes prior to its start time. Anyone listening to the
webcast will be presumed to have read Health Net’s Annual Report on
Form 10-K for the year ended December 31, 2013, Quarterly
Reports on Form 10-Q for the quarterly periods ended March 31,
2014, June 30, 2014, and September 30, 2014, and other
reports filed by the company from time to time with the Securities
and Exchange Commission.
About Health Net
Health Net, Inc. is a publicly traded managed care organization
that delivers managed health care services through health plans and
government-sponsored managed care plans. Its mission is to help
people be healthy, secure and comfortable. Health Net provides and
administers health benefits to approximately 5.9 million
individuals across the country through group, individual, Medicare
(including the Medicare prescription drug benefit commonly referred
to as “Part D”), Medicaid, U.S. Department of Defense, including
TRICARE, and Veterans Affairs programs. Health Net also offers
behavioral health, substance abuse and employee assistance
programs, managed health care products related to prescription
drugs, managed health care product coordination for multi-region
employers, and administrative services for medical groups and
self-funded benefits programs.
For more information on Health Net, Inc., please visit Health
Net’s website at www.healthnet.com.
Cautionary Statements
The company and its representatives may from time to time make
written and oral forward-looking statements within the meaning of
the Private Securities Litigation Reform Act (“PSLRA”) of 1995,
including statements in this and other press releases, in
presentations, filings with the Securities and Exchange Commission
(“SEC”), reports to stockholders and in meetings with investors and
analysts. All statements in this press release, other than
statements of historical information provided herein, may be deemed
to be forward-looking statements and as such are intended to be
covered by the safe harbor for “forward-looking statements”
provided by PSLRA. These statements are based on management’s
analysis, judgment, belief and expectation only as of the date
hereof, and are subject to changes in circumstances and a number of
risks and uncertainties. Without limiting the foregoing, statements
including the words “believes,” “anticipates,” “plans,” “expects,”
“may,” “should,” “could,” “estimate,” “intend,” “feels,” “will,”
“projects” and other similar expressions are intended to identify
forward-looking statements. Actual results could differ materially
from those expressed in, or implied or projected by the
forward-looking information and statements due to, among other
things, health care reform and other increased government
participation in and taxation or regulation of health benefits and
managed care operations, including but not limited to the
implementation of the Patient Protection and Affordable Care Act
and the Health Care and Education Reconciliation Act of 2010
(collectively, the "ACA") and related fees, assessments and taxes;
the company’s ability to successfully participate in California’s
Coordinated Care Initiative, which is subject to a number of risks
inherent in untested health care initiatives and requires the
company to adequately predict the costs of providing benefits to
individuals that are generally among the most chronically ill
within each of Medicare and Medi-Cal and implement delivery systems
for benefits with which the company has limited operating
experience; the company’s ability to successfully participate in
the federal and state health insurance exchanges under the ACA,
which in the past have experienced technical challenges in
implementation and which involve uncertainties related to the mix
and volume of business that could negatively impact the adequacy of
the company’s premium rates and may not be sufficiently offset by
the risk apportionment provisions of the ACA; increasing health
care costs, including but not limited to costs associated with the
introduction of new treatments or therapies; the company’s ability
to reduce administrative expenses while maintaining targeted levels
of service and operating performance, including through the
company’s master services agreement with Cognizant; whether the
company receives required regulatory approvals for Cognizant’s
provision of services to the company and any conditions imposed in
order to obtain such regulatory approvals; the company’s ability to
recognize the intended cost savings and other intended benefits of
the Cognizant transaction; and the risk that Cognizant may not
perform contracted functions and services in a timely, satisfactory
and compliant manner; negative prior period claims reserve
developments; rate cuts and other risks and uncertainties affecting
the company’s Medicare or Medicaid businesses; trends in medical
care ratios; membership declines or negative changes in the
company’s health care product mix; unexpected utilization patterns
or unexpectedly severe or widespread illnesses; the timing of
collections on amounts receivable from state and federal
governments and agencies, including collections of amounts owed
under the T-3 contract; litigation costs; regulatory issues with
federal and state agencies including, but not limited to, the
California Department of Managed Health Care and Department of
Health Care Services, the Centers for Medicare & Medicaid
Services, the Office of Civil Rights of the U.S. Department of
Health and Human Services and state departments of insurance;
operational issues; changes in economic or market conditions;
failure to effectively oversee the company’s third-party vendors;
noncompliance by the company or the company’s business associates
with any privacy laws or any security breach involving the
misappropriation, loss or other unauthorized use or disclosure of
confidential information; impairment of the company’s goodwill or
other intangible assets; investment portfolio impairment charges;
volatility in the financial markets; and general business and
market conditions. Additional factors that could cause actual
results to differ materially from those reflected in the
forward-looking statements include, but are not limited to, the
risks discussed in the “Risk Factors” section included within the
company’s most recent Annual Report on Form 10-K and subsequent
Quarterly Reports on Form 10-Q filed with the SEC and the other
risks discussed in the company’s filings with the SEC. Readers are
cautioned not to place undue reliance on these forward-looking
statements. Except as may be required by law, the company
undertakes no obligation to address or publicly update any
forward-looking statements to reflect events or circumstances that
arise after the date of this release.
Investor Contact:The Abernathy MacGregor GroupDavid
Olson, (818) 917-1469dwo@abmac.comorMedia Contact:Health
Net, Inc.Brad Kieffer, (818) 676-6833brad.kieffer@healthnet.com
Health Net (NYSE:HNT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Health Net (NYSE:HNT)
Historical Stock Chart
From Sep 2023 to Sep 2024